Prof Patrick Ogwang, the renowned innovator of Covidex, a supplementary herbal remedy to COVID treatment, recently given the National Drug Authority’s green light, says he needs UGX 2BN to conduct more clinical trials for the drug.
The drugs authority early this month gave a green light for the use of Covidex in the treatment of viral infections, including covid-19 patients. This came amidst statements that there was no concrete medical proof that COVIDEX completely cures COVID-19.
In an interview with NTV, Prof Ogwang revealed that to do clinical trials, he would need about Shs2bn, as the process is lengthy and involves hiring the expensive services of highly skilled professionals.
He adds that even with the sales made so far, they have not even raised half a billion shillings.